These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 10481776)

  • 41. Combination chemotherapy of cisplatin, methotrexate, vinblastine, and high-dose tamoxifen for transitional cell carcinoma.
    Hsu CH; Chen J; Wu CY; Cheng AL; Pu YS
    Anticancer Res; 2001; 21(1B):711-5. PubMed ID: 11299831
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Simultaneous radiochemotherapy in cervical cancer: recommendations for chemotherapy.
    Dunst J; Haensgen G
    Strahlenther Onkol; 2001 Dec; 177(12):635-40. PubMed ID: 11789401
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [A case of squamous cell carcinoma of the bladder that was successfully treated with multidisciplinary therapies].
    Matsumoto S; Nishioka T; Akiyama T; Park YC; Kurita T; Ishikawa Y
    Hinyokika Kiyo; 2001 Jan; 47(1):43-6. PubMed ID: 11235221
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Overview of bladder cancer trials in the European Organization for Research and Treatment.
    de Wit R;
    Cancer; 2003 Apr; 97(8 Suppl):2120-6. PubMed ID: 12673705
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Chemoradiotherapy for muscle invading bladder carcinoma. Final report of a single institutional organ-sparing program.
    Droller MJ
    J Urol; 2002 May; 167(5):2297-8. PubMed ID: 11956495
    [No Abstract]   [Full Text] [Related]  

  • 46. Neoadjuvant and adjuvant chemotherapy in muscle-invasive bladder cancer.
    Calabrò F; Sternberg CN
    Eur Urol; 2009 Feb; 55(2):348-58. PubMed ID: 18977070
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Adjuvant and neoadjuvant chemotherapy for invasive bladder cancer.
    Natale RB
    Curr Oncol Rep; 2000 Sep; 2(5):386-93. PubMed ID: 11122869
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Integration of neoadjuvant and adjuvant chemotherapy and cystectomy in the treatment of muscle-invasive bladder cancer.
    Milowsky MI; Stadler WM; Bajorin DF
    BJU Int; 2008 Nov; 102(9 Pt B):1339-44. PubMed ID: 19035902
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Does neoadjuvant cisplatin-based chemotherapy improve the survival of patients with locally advanced bladder cancer: a meta-analysis of individual patient data from randomized clinical trials. Advanced bladder cancer overview collaboration.
    Scher HI
    J Urol; 1995 Nov; 154(5):1970. PubMed ID: 7563394
    [No Abstract]   [Full Text] [Related]  

  • 50. Resume of selected studies of the National Bladder Cancer Collaborative Group A and new protocols.
    Prout GR; Kopp J
    Prog Clin Biol Res; 1984; 162B():397-427. PubMed ID: 6438644
    [No Abstract]   [Full Text] [Related]  

  • 51. New chemoradiation approach for bladder cancer tested in RTOG 95-06.
    Oncology (Williston Park); 1995 Nov; 9(11):1144. PubMed ID: 8703683
    [No Abstract]   [Full Text] [Related]  

  • 52. Adjuvant chemotherapy in advanced bladder cancer. Italian Uro-Oncologic Cooperative Group.
    Bono AV; Benvenuti C; Reali L; Pozzi E; Gibba A; Cosciani-Cunico S; Comuzzi U; Anselmo G
    Prog Clin Biol Res; 1989; 303():533-40. PubMed ID: 2675010
    [No Abstract]   [Full Text] [Related]  

  • 53. Combined systemic therapy and radiotherapy for bladder cancer.
    Rödel C; Weiss C; Sauer R
    Strahlenther Onkol; 2007 Dec; 183 Spec No 2():29-31. PubMed ID: 18167005
    [No Abstract]   [Full Text] [Related]  

  • 54. The evolution of active chemotherapy in metastatic and locally advanced bladder cancer.
    Newling DW
    Prog Clin Biol Res; 1990; 350():115-27. PubMed ID: 2201038
    [No Abstract]   [Full Text] [Related]  

  • 55. [Non-adjuvant chemotherapy of bladder neoplasms stage T3-4 using NO-x and MO. Preliminary results of the urogenital study group of the European Organization for Research and Treatment of Cancer].
    Bollack C; Jacqmin D; Splinter TA; De Pauw M
    Cas Lek Cesk; 1988 Aug; 127(35):1098-100. PubMed ID: 3197062
    [No Abstract]   [Full Text] [Related]  

  • 56. [Plasma concentration of 4'-epi-adriamycin in hemodialysis patients].
    Tomoe H; Nishino S; Koyama I; Uda M; Toma H
    Gan To Kagaku Ryoho; 1992 Apr; 19(4):549-51. PubMed ID: 1558406
    [No Abstract]   [Full Text] [Related]  

  • 57. Time for a change.
    Hryniuk W
    Cancer J Sci Am; 1997; 3(4):209-10. PubMed ID: 9263625
    [No Abstract]   [Full Text] [Related]  

  • 58. TUR and chemotherapy or radiotherapy for invasive bladder cancer.
    Hall RR; Roberts T; Powell PH; Marsh MM
    Prog Clin Biol Res; 1988; 260():605-12. PubMed ID: 3129740
    [No Abstract]   [Full Text] [Related]  

  • 59. A pharmacogically guided phase I study of carboplatin in combination with methotrexate and vinblastine in advanced urothelial cancer.
    Scher HI
    J Urol; 1995 Nov; 154(5):1970-1. PubMed ID: 7563395
    [No Abstract]   [Full Text] [Related]  

  • 60. Cytotoxic and DNA-targeted therapy in urothelial cancer: have we squeezed the lemon enough?
    Balar AV; Milowsky MI
    Cancer; 2015 Jan; 121(2):179-87. PubMed ID: 25091501
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.